Background.-Lead freely crosses the placenta. Consequently, gestational lead poisoning is not only harmful to the woman but also to the developing fetus, invariably producing congenital lead poisoning. The scope and consequences of severe lead poisoning in pregnancy (blood lead level 245 fg/dL) have not been well characterized.
C hildhood lead poisoning, although decreasing in prevalence, continues to affect an estimated 900 000 children. 1 Efforts to prevent lead poison ing rely on the identification of common sources and ap propriate preventive interventions. Potentially included among lead sources of importance is in utero lead trans mission. According to recent estimates, as many as 0.5% of women of childbearing age may have blood lead levels >10 fg/dL. 2 Because lead freely crosses the placenta, neonatal lead poisoning is always the expected result of lead poisoning in the pregnant woman. 3 Severe lead poisoning (blood lead level 245 fg/dL) occasionally occurs in pregnant women. However, despite several published case reports of this condition over the last 30 years, there has been no effort to characterize its etiology and characteristics. Over the last 3 years, our Pe diatric Environmental Specialty Unit has consulted in the care of pregnant women discovered to have severe lead poisoning. We reviewed our experience with these pa tients, additionally conducting a 25-year review of the medical literature to identify similar cases. Our purpose was to describe the epidemiologic and toxicologic aspects Address correspondence to Michael Shannon, MD, MPH, Chil dren's Hospital, 300 Longwood Ave, Boston, MA 02115 (e-mail: michael.shannon@tch.harvard.edu).
Received for publication May 17, 2001 ; accepted August 15, 2001. of severe lead poisoning in pregnancy as well as shortterm neonatal outcomes.
RESULTS
Over a 3-year period we assisted in the care of 7 severely lead-poisoned women. A Medline search identified an ad ditional 8 cases (Table) . Among the 15 women in whom ethnic origin was identified, 7 (70%) were of Hispanic ori gin, 2 were from India, and 1 was Caucasian; ethnicity was unstated in 5 cases. Mean gestational age at the time of diagnosis was 32 weeks, with all but 2 women in their third trimester. Initial maternal blood lead level was 72 : 27 fg/ dL. All women presented with malaise, fatigue, and anemia; in 2 cases the presence of basophilic stippling led to the diagnosis. One woman requested a blood lead measurement after she completed a household renovation project.
Where the source of lead poisoning was identified, 10 (83%) women admitted to intentional pica during preg nancy. In the Latina women, pica took the form of ''tierra,'' or ingestion of soil/clay-based substances, in cluding clay pottery. Additional etiologies were home ren ovation and daily use of lead-contaminated bone meal, which was taken as a calcium supplement.
Five women underwent chelation while they were preg nant for a mean lead level of 86 fg/dL. Four received parenteral CaNa 2 EDTA, including one woman who also received intramuscular dimercaprol (BAL); one woman received succimer. The remaining 10 women carried the pregnancy to term without undergoing chelation. No ad verse effects on either the mother or fetus were observed during chelation. At the time of delivery, mean maternal lead level was 55 : 19 fg/dL; where reported, mean hematocrit was 29.5% (range 23%-32%). The corresponding neonatal lead level was a mean 74 : 44 fg/dL (range 26-207 fg/ dL), with hematocrit ranging from 35% to 52%. Neonatal blood levels correlated well with maternal level (Pearson bivariate correlation, r = 0.72, P = .008). Although mean neonatal blood lead level was significantly greater than maternal level (P = .009), newborn values ranged from 99% higher to 112% lower than maternal specimens, with a mean of 32% greater.
No newborn had an identifiable birth defect in the cur rent series. However, among cases reported in the litera ture, neonates had skeletal abnormalities, including de layed skeletal maturation and distal long-bone sclerosis. Thirteen newborns underwent chelation therapy, all within the first 28 days of life, receiving EDTA, BAL, or suc cimer. No adverse effects of chelation were observed in the neonates. Neurodevelopmental monitoring is ongoing.
Case Descriptions

Case #8
A woman in her 25th week of gestation was found to have a blood lead level of 62 fg/dL, with a corresponding hematocrit of 23%. She received oral chelation with suc cimer. At term she delivered a healthy-appearing female. At delivery the maternal lead level was 58 fg/dL, where as cord blood lead level was 126 fg/dL and neonatal lead level was 75 fg/dL. The newborn underwent chelation with parenteral BAL and EDTA.
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Case #2
A Hispanic woman presented to her obstetrician at 36 weeks with a lead level of 49 fg/dL. After repeated ques tioning, she admitted to the ingestion of clay pottery, de scribing this as a common practice in her culture. She did not undergo chelation. Labor began spontaneously at 36 weeks, with birth of a healthy-appearing female. At de livery maternal lead level was 49 fg/dL; simultaneous neonatal lead level was 51 fg/dL. Neither mother nor infant underwent chelation.
DISCUSSION
In addition to the 15 cases described here, there have been other reports of severe gestational lead poisoning published in the last century. [6] [7] [8] Collectively, these cases illustrate several consistent aspects of this poisoning, pro viding some insight into its causes and effects. For ex ample, all cases resulted from one of 3 factors: intentional pica, home renovation, or use of a dietary supplement. Ingestion of soil or clay during pregnancy is a common practice among many ethnic groups 9, 10 ; this series indi cates that pica during pregnancy is a significant risk factor for lead exposure. The case of renovation-associated lead poisoning illustrates the risk to pregnant women of par ticipating in household renovation activities. 11 Finally, use of complementary/alternative medications has resulted in many reported cases of adult and childhood lead poison ing. [12] [13] [14] Bone meal and shells, often used as calcium sup plements during pregnancy, have frequently been found to be lead-contaminated. [15] [16] [17] Transplacental transmission of lead occurs by simple diffusion, with neonatal blood lead levels approximating those of the mother in most series. 2, 3, [18] [19] [20] However, uptake of lead by the fetus is cumulative over time, indicating a net unidirectional flow. 2, 18 Additionally, data by Rothen berg and others 18, 21 indicate that neonatal lead levels tend to be higher in the offspring of women with low calcium intakes.
An important but confounding factor in the interpreta tion of blood lead levels is hematocrit. Ninety-nine per cent of circulating lead is bound to the erythrocyte. There fore, in the presence of anemia, whether it is caused by iron deficiency or lead-induced suppression of hemato poiesis, blood lead level will be deceptively low. Con versely, because neonates typically have a hematocrit of 50%-60%, potentially as much as twice the maternal con centration, neonatal blood lead level will be markedly el evated (unless there is concomitant anemia).
Five women underwent chelation, all during the second or third trimester of pregnancy, with no obvious adverse effects to either the woman or fetus. Chelation was con ducted in accordance with current guidelines, placing the mother's health as the treatment priority. 2 There are no known dangers of chelation therapy to pregnant women. Fetal effects are also uncertain; although experimental data have suggested that the elimination of essential min erals by chelation is teratogenic, there are no reports of chelation-associated birth defects in humans. 2, 22 Nonethe less, chelation therapy potentially carries the added risk of mobilizing maternal lead stores such that lead trans mission to the fetus increases. These observations support current recommendations that chelation during pregnancy be preserved for severe, symptomatic lead poisoning.
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The consequences of severe in utero lead poisoning on the newborn are unclear. No infant demonstrated overt signs of severe lead toxicity (eg, seizures). However, ra diographic abnormalities, including delayed skeletal mat uration and long-bone sclerosis, 24 are recognized conse quences. Profound delays in the appearance of primary dentition may also occur, with the first tooth appearing as late as 30 months of age. 7, 25 Other reported effects of lead on the fetus include intrauterine growth retardation, con genital anomalies, and neurobehavioral deficits. 2, 26, 27 These cases indicate a role for targeted lead screening in pregnant women. 28, 29 Use of a modified childhood ques tionnaire for lead exposure has been shown to be a useful aid in identifying lead-exposed women. 29 Based on our findings, a history of pica or use of a complementary/ alternative medication during pregnancy may also be use ful predictors of lead exposure. Prompt identification of such women would help to eliminate additional exposure and provide a lead-safe environment both for the woman and infant.
